Horizon BioAdvance Receives Award for Excellence in Clinical Trials

Posted On 07/02/2014

July 2, 2014

Lafayette, IN – Horizon BioAdvance announced today that it is one of only eight community oncology practices in the country recognized by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) for its commitment to high-quality clinical trials programs. As a recipient of the Conquer Cancer Foundation of ASCO Clinical Trials Participation Award, Horizon BioAdvance is being honored for its contribution to the improvement of cancer care through clinical research in a community-based setting.

“Our number one goal is to provide our patients with the best possible care available. On average, 25% of our patients are participating in a cancer clinical trials,” said Dr. Wael Harb,Horizon BioAdvance is honored to have been chosen for this award.”

Practices were selected to receive the award based on several different criteria, which emphasize high patient accrual in clinical trials by overcoming barriers to enrollment. Preference was also given to practices with clinical trials programs that serve and connect with underrepresented populations in their communities.

“The Conquer Cancer Foundation of the American Society of Clinical Oncology is pleased to honor Horizon BioAdvance with the Clinical Trials Participation Award for providing patients with access to high-quality clinical research that furthers our progress against cancer,” said W. Charles Penley, MD, FASCO, Chair of the Conquer Cancer Foundation Board of Directors. 

The Clinical Trials Participation Award is funded through the Conquer Cancer Foundation of ASCO with the generous support of the Coalition of Cancer Cooperative Groups, which has supported the award since it was established in 2003.

 For more information regarding clinical trial participation at Horizon BioAdvance, please contact Beth Morris at 765-446-5111, or visit www.horizonbioadvance.com for a complete list of available clinical trials.


About Horizon BioAdvance

Horizon BioAdvance is a biomedical research company that offers safe, ethical, cutting-edge medical care and up-to-date technologies to our patients and volunteers.  Horizon has a history of success in site management, translational research, and research consulting and collaboration.  For more information, visit www.horizonbioadvance.com.


About the Conquer Cancer Foundation

The Conquer Cancer Foundation (CCF) was created by the world’s foremost cancer doctors of the American Society of Clinical Oncology to seek dramatic advances in the prevention, treatment and cures of all types of cancer. Toward the vision of a world free from the fear of cancer, CCF works to conquer this disease by funding breakthrough cancer research and sharing cutting-edge knowledge with patients and physicians worldwide, and by improving quality of care and access to care, enhancing the lives of all who are touched by cancer.  For more information, visit www.conquercancerfoundation.org.


# # #